KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Labcorp Holdings (LH) Payables (2016 - 2026)

Labcorp Holdings' Payables history spans 18 years, with the latest figure at $695.7 million for Q1 2026.

  • On a quarterly basis, Payables fell 3.09% to $695.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was $695.7 million, a 3.09% decrease, with the full-year FY2025 number at $840.8 million, down 4.0% from a year prior.
  • Payables hit $695.7 million in Q1 2026 for Labcorp Holdings, down from $840.8 million in the prior quarter.
  • Over the last five years, Payables for LH hit a ceiling of $2.8 billion in Q2 2024 and a floor of $625.2 million in Q1 2022.
  • Historically, Payables has averaged $1.2 billion across 5 years, with a median of $875.8 million in 2024.
  • Biggest five-year swings in Payables: surged 174.04% in 2024 and later tumbled 73.77% in 2025.
  • Tracing LH's Payables over 5 years: stood at $1.2 billion in 2022, then skyrocketed by 58.41% to $1.8 billion in 2023, then crashed by 52.07% to $875.8 million in 2024, then dropped by 4.0% to $840.8 million in 2025, then decreased by 17.26% to $695.7 million in 2026.
  • Business Quant data shows Payables for LH at $695.7 million in Q1 2026, $840.8 million in Q4 2025, and $668.5 million in Q3 2025.